Treasury yields inch higher after only slight increase in jobless claims
U.S. government debt sold off modestly Thursday morning, pushing yields slightly higher, as data on weekly initial jobless-benefit claims showed businesses remain reluctant to lay...
Tesla’s deliveries didn’t live up to the hype. What investors should watch next.
One analyst sees the upcoming Robotaxi event as “the next potential catalyst” for Tesla’s stock, while another senses some anxiety around it.
Nano Dimension moves closer to closing Desktop Metal deal after shareholder vote
The proposed merger of 3-D printing companies Nano Dimension Ltd. and Desktop metal Inc. moved closer to completion on Thursday, after Desktop Metal shareholders voted...
This shipping stock is ‘in an enviable position’ for a protracted port strike, says analyst
While a prolonged strike at East Coast and Gulf ports would spell bad news for the U.S. economy, it could provide a boost to shipping...
September surprise? U.S. jobs report holds key to Fed rate cuts.
The U.S. jobs report has overtaken inflation as the chief worry of the Federal Reserve as it plots how fast to cut interest rates.
OpenAI making money from the AI revolution is far from certain
Being at the cutting edge doesn’t necessarily bring financial success.
Jobless claims inch higher, but still no sign of major U.S. layoffs
The number of Americans who applied for unemployment benefits last week rose slightly to a minuscule 225,000, affirming that layoffs remain surprisingly low even though...
Why Salesforce’s stock is getting more love from Wall Street analysts lately
Salesforce shares have lagged the S&P 500 this year but could be primed for bigger gains thanks to improved product positioning.
Eli Lilly’s weight-loss and diabetes drugs are no longer in shortage, says FDA
The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are no longer in shortage signaling that...